Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Advanced Solid Cancers × Clear all

Phase

Phase 1 6 Phase 1/2 2 Phase EARLY_PHASE1 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 102 Neoplasms 92 Carcinoma, Non-Small-Cell Lung 69 Colorectal Neoplasms 66 Prostatic Neoplasms 65 Carcinoma, Hepatocellular 59 Leukemia, Myeloid, Acute 52 Stomach Neoplasms 48 Neoplasm Metastasis 46 Precursor Cell Lymphoblastic Leukemia-Lymphoma 41 Lung Neoplasms 41 Pancreatic Neoplasms 36 Recurrence 31 Rectal Neoplasms 27 Multiple Myeloma 27 Colonic Neoplasms 26 Leukemia 24 Head and Neck Neoplasms 23 Ovarian Neoplasms 22 Squamous Cell Carcinoma of Head and Neck 21 Lymphoma 21 Hematologic Neoplasms 20 Myelodysplastic Syndromes 18 Esophageal Neoplasms 18 Urinary Bladder Neoplasms 17 Polycystic Ovary Syndrome 17 Lymphoma, Large B-Cell, Diffuse 16 Melanoma 15 Liver Neoplasms 15 Glioblastoma 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07290088 2025-12-23

PRL3-zumab

Intra-IMMUSG Pte Ltd

Phase 2/3 Recruiting

Advanced Solid Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡